147 related articles for article (PubMed ID: 17826334)
1. Modeling the molecular basis of atovaquone resistance in parasites and pathogenic fungi.
Kessl JJ; Meshnick SR; Trumpower BL
Trends Parasitol; 2007 Oct; 23(10):494-501. PubMed ID: 17826334
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for atovaquone resistance in Pneumocystis jirovecii modeled in the cytochrome bc(1) complex of Saccharomyces cerevisiae.
Kessl JJ; Hill P; Lange BB; Meshnick SR; Meunier B; Trumpower BL
J Biol Chem; 2004 Jan; 279(4):2817-24. PubMed ID: 14576156
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for atovaquone binding to the cytochrome bc1 complex.
Kessl JJ; Lange BB; Merbitz-Zahradnik T; Zwicker K; Hill P; Meunier B; Pálsdóttir H; Hunte C; Meshnick S; Trumpower BL
J Biol Chem; 2003 Aug; 278(33):31312-8. PubMed ID: 12791689
[TBL] [Abstract][Full Text] [Related]
4. Direct evidence for the atovaquone action on the Plasmodium cytochrome bc1 complex.
Siregar JE; Kurisu G; Kobayashi T; Matsuzaki M; Sakamoto K; Mi-ichi F; Watanabe Y; Hirai M; Matsuoka H; Syafruddin D; Marzuki S; Kita K
Parasitol Int; 2015 Jun; 64(3):295-300. PubMed ID: 25264100
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome b mutations that modify the ubiquinol-binding pocket of the cytochrome bc1 complex and confer anti-malarial drug resistance in Saccharomyces cerevisiae.
Kessl JJ; Ha KH; Merritt AK; Lange BB; Hill P; Meunier B; Meshnick SR; Trumpower BL
J Biol Chem; 2005 Apr; 280(17):17142-8. PubMed ID: 15718226
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action.
Birth D; Kao WC; Hunte C
Nat Commun; 2014 Jun; 5():4029. PubMed ID: 24893593
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis Cytochrome b Mutants Associated With Atovaquone Prophylaxis Failure as the Cause of Pneumocystis Infection Outbreak Among Heart Transplant Recipients.
Argy N; Le Gal S; Coppée R; Song Z; Vindrios W; Massias L; Kao WC; Hunte C; Yazdanpanah Y; Lucet JC; Houzé S; Clain J; Nevez G
Clin Infect Dis; 2018 Aug; 67(6):913-919. PubMed ID: 29514207
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite results in reduced parasite bc1 catalytic turnover and protein expression.
Fisher N; Abd Majid R; Antoine T; Al-Helal M; Warman AJ; Johnson DJ; Lawrenson AS; Ranson H; O'Neill PM; Ward SA; Biagini GA
J Biol Chem; 2012 Mar; 287(13):9731-9741. PubMed ID: 22282497
[TBL] [Abstract][Full Text] [Related]
9. Reconstructing the Qo site of Plasmodium falciparum bc 1 complex in the yeast enzyme.
Vallières C; Fisher N; Meunier B
PLoS One; 2013; 8(8):e71726. PubMed ID: 23951230
[TBL] [Abstract][Full Text] [Related]
10. Parameters determining the relative efficacy of hydroxy-naphthoquinone inhibitors of the cytochrome bc1 complex.
Kessl JJ; Moskalev NV; Gribble GW; Nasr M; Meshnick SR; Trumpower BL
Biochim Biophys Acta; 2007 Apr; 1767(4):319-26. PubMed ID: 17383607
[TBL] [Abstract][Full Text] [Related]
11. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology of malaria in Cameroon. XVII. Baseline monitoring of atovaquone-resistant Plasmodium falciparum by in vitro drug assays and cytochrome b gene sequence analysis.
Basco LK
Am J Trop Med Hyg; 2003 Aug; 69(2):179-83. PubMed ID: 14506774
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting Plasmodium cytochrome bc1: a complex issue.
Barton V; Fisher N; Biagini GA; Ward SA; O'Neill PM
Curr Opin Chem Biol; 2010 Aug; 14(4):440-6. PubMed ID: 20570550
[TBL] [Abstract][Full Text] [Related]
14. The interaction of atovaquone with the P. carinii cytochrome bc1 complex.
Meshnick SR; Berry EA; Nett J; Kazanjian P; Trumpower B
J Eukaryot Microbiol; 2001; Suppl():169S-171S. PubMed ID: 11906048
[No Abstract] [Full Text] [Related]
15. Saccharomyces cerevisiae-based mutational analysis of the bc1 complex Qo site residue 279 to study the trade-off between atovaquone resistance and function.
Song Z; Clain J; Iorga BI; Yi Z; Fisher N; Meunier B
Antimicrob Agents Chemother; 2015 Jul; 59(7):4053-8. PubMed ID: 25918152
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of tetracyclic benzothiazepines as Plasmodium falciparum cytochrome bc1 inhibitors.
Dong CK; Urgaonkar S; Cortese JF; Gamo FJ; Garcia-Bustos JF; Lafuente MJ; Patel V; Ross L; Coleman BI; Derbyshire ER; Clish CB; Serrano AE; Cromwell M; Barker RH; Dvorin JD; Duraisingh MT; Wirth DF; Clardy J; Mazitschek R
Chem Biol; 2011 Dec; 18(12):1602-10. PubMed ID: 22195562
[TBL] [Abstract][Full Text] [Related]
17. Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone.
Skinner-Adams TS; Fisher GM; Riches AG; Hutt OE; Jarvis KE; Wilson T; von Itzstein M; Chopra P; Antonova-Koch Y; Meister S; Winzeler EA; Clarke M; Fidock DA; Burrows JN; Ryan JH; Andrews KT
Commun Biol; 2019; 2():166. PubMed ID: 31069275
[TBL] [Abstract][Full Text] [Related]
18. Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites.
Srivastava IK; Morrisey JM; Darrouzet E; Daldal F; Vaidya AB
Mol Microbiol; 1999 Aug; 33(4):704-11. PubMed ID: 10447880
[TBL] [Abstract][Full Text] [Related]
19. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
[TBL] [Abstract][Full Text] [Related]
20. Probing binding determinants in center P of the cytochrome bc(1) complex using novel hydroxy-naphthoquinones.
Hughes LM; Covian R; Gribble GW; Trumpower BL
Biochim Biophys Acta; 2010 Jan; 1797(1):38-43. PubMed ID: 19660431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
